Chemoprevention of DMBA-induced mammary carcinogenesis: Relationship between induction of phase II enzymes, effects on DMBA-induced hemoglobin adducts and decreases in mammary tumor multiplicity

Polycyclic Aromatic Compounds

Volumn 18, Issue 2, 2000, Pages 193-210

  Song, Lynda L ^a   Myers, Steven R ^d   Lantvit, Dan ^b   Lubet, Ronald A ^c   Steele, Vernon E ^c   Kelloff, Gary J ^c   Moon, Richard C ^b   Pezzuto, John M ^a,b,d  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d University of Louisville School of Medicine   (United States)

Author keywords

Antioxidants; Biomarkers; Carcinogens; DMBA; Hemoglobin; Tumors

Indexed keywords

CARCINOGENS; ENZYMES; HEMOGLOBIN; METABOLISM; PATHOLOGY; PEPTIDES; PHYSIOLOGY;

CARCINOGENESES; DMBA; ETHOXYQUIN; HAEMOGLOBINS; HEMOGLOBIN ADDUCTS; HIGH DOSE; MAMMARY TUMORS; PHASE II; THIONES; Β-NAPHTHOFLAVONE;

TUMORS;

EID: 0034561538     PISSN: 10406638     EISSN: None     Source Type: Journal    
DOI: 10.1080/10406630008028145     Document Type: Article

References (26)

1. Sugimura, T. (1982). Cancer, 49, 1974.
2. Sugimura, T. (1988). Trends Pharmacol. Sci., 9, 205.
3. Sugimura, T. (1986). Science, 233, 312.
4. Wattenberg, L. W. (1985). Cancer Res., 45, 1.
5. Talalay, P., Fahey, J. W., Holtzclaw, W. D., Prestera, T. and Zhang, Y. (1995). Toxicol. Lett., 82-83, 173.
6. Talalay, P., De Long, M. G., Prochaska, H. J., Cory, J. G. and Szentivani, A. (Eds.) (1987). Cancer Biology and Therapeutics, Plenum Press, New York, p. 197.
7. Prestera, T., Holtzclaw, W. D., Zhang, Y. and Talalay, P. (1993). Proc. Natl. Acad. Sci. USA, 90, 2965.
8. Talalay, P. (1992). Cancer Chemoprevention, CRC Press. Inc., p. 469.
9. Huggins, C., Grand, L. C. and Brillantes, F. P. (1987). Nature, 189, 204.
10. Grover, P. L. (1986). Xenobiotica, 16, 915.
11. Wislocki, P. G., Gadek, K. M., Chou, M. W., Yang, S. K. and Lu, Y. H. (1980). Cancer Res., 40, 3661.
12. McCord, A., Burnett, A. K., Wolf, C. R., Morrison, V. M. and Craft, J. A. (1988). Carcinogenesis, 9, 1485.
13. Morrison, V. M., Burnett, A. K. and Craft, J. A. (1991). Biochem. Pharmacol., 41, 1505.
14. Vigny, P., Brunissen, A., Phillips, D. H., Cooper, C. S., Hewer, A., Grover, P. L. and Sims, P. (1985). Cancer Lett., 26, 51.
15. Cheng, S. C., Prakash, A. S., Pigott, M. A., Hilton, B. D., Lee, H., Harvey, R. G. and Dipple, A. (1988). Carcinogenesis, 9, 1721.
16. Sawicke, J., Moschel, R. C. and Dipple, A. (1983). Cancer Res., 43, 3212.
17. Gerhäuser, C., You, M., Liu, J., Moriarty, R. M., Hawthorne, M., Mehta, R. G., Moon, R. C. and Pezzuto, J. M. (1997). Cancer Res., 57, 272.
18. Buetler, T. W., Gallagher, E. P., Wang, C. and Stahl, D. L. (1995). Toxicol. Appl. Pharmacol., 135, 45.
19. Egner, P. A., Kensler, T. W., Prestera, T., Talalay, P., Libby, A. H., Joyner, H. H. and Curphey, T. J. (1994). Carcinogenesis, 15, 177.
20. Benson, A. M., Hundeler, M. J. and Talalay, P. (1980). Proc. Natl. Acad. Sci. USA, 77, 5216.
21. Lam, L. K., Pai, R. P. and Wattenberg, L. W. (1979). J. Biol. Chem., 22, 569.
22. Wattenberg, L. W. (1973). J. Natl. Cancer Inst., 50, 1541.
23. Wattenberg, L. W. (1972). J. Natl. Cancer Inst., 48, 142.
24. William, G. M., Tanaka, T. and Maeura, Y. (1986). Carcinogenesis, 7, 1043.
25. Mandel, H. G., Manson, M. M. and Judah, D. J. (1987). Cancer Res., 47, 5218.
26. Cabral, J. R. P. and Neal, G. E. (1983). Cancer Lett., 19, 125.